WELCOME TO JOHNS HOPKINS HEALTH ALERTS!

This free public service from Johns Hopkins Medicine helps keep you up to date on the latest breakthroughs for the most common medical conditions which prevent healthy aging. Browse all the articles via the Health Alert Topics navigation bar on the right, or read the headlines below.


Get the latest news sent straight to your Inbox. Register now for your FREE Johns Hopkins Health Alerts. Check the boxes below for all the topics you are interested in, enter your email address, and click "Send." It's fast, easy, and FREE.   Benefits of Being A Registered User

Enter your email here: (Example: yourname@domain.com)
Please send my alerts as:

We value your privacy and will never rent your email address.Already a Member? Manage your Health Alerts


Johns Hopkins Health Alert

Propecia and Your PSA

Comments (1)

If you're a man who takes the hair-growth drug Propecia, you should let your doctor know before you have your next PSA test, as it could affect the accuracy of the results.

The prostate-specific antigen (PSA) test measures an enzyme produced almost exclusively by the glandular cells of the prostate. It is secreted during ejaculation into the prostatic ducts that empty into the urethra. PSA liquefies semen after ejaculation, promoting the release of sperm.

Normally, only very small amounts of PSA are present in the blood. But an abnormality of the prostate can disrupt the normal architecture of the gland and create an opening for PSA to pass into the bloodstream. Thus, high blood levels of PSA can indicate prostate problems, including cancer.

A blood test to measure levels of PSA was first approved by the U.S. Food and Drug Administration (FDA) in 1986 as a way to determine whether prostate cancer had been treated successfully and to monitor for its recurrence. Today, however, PSA tests are FDA approved for prostate cancer detection and are widely used to screen men for the disease.

 

Now research suggests that the hair-growth medication Propecia (finasteride) significantly lowers a man's PSA level, producing misleading results and potentially masking the presence of prostate cancer.

 

Propecia is the same medication as Proscar, which is used to control benign prostatic hyperplasia (BPH). The difference is the dosage -- 5 mg per day for Proscar vs. 1 mg for Propecia. Proscar is known to artificially lower PSA levels by about half, and doctors interpreting PSA results in these men compensate by doubling the PSA value. But Propecia's impact on PSA level has not been formally studied until now.

The researchers in the study which was reported in the journal Lancet Oncology (Volume 8, page 21) assigned 355 men age 40-60 to take either Propecia or a placebo (inactive pill) for 48 weeks. For analysis purposes, the men were grouped by age: 40-49 and 50-60. By the end of the study period, PSA levels among men in the younger group had dropped by an average of 40%; in the older group, PSA declined by an average of 50%. Among men taking the placebo, the PSA levels of the younger men had not changed, and the levels of the older men had risen by an average of 13%.

Bottom Line: If you use Propecia, be sure to let your physician know so that your PSA results can be adjusted accordingly.

Posted in Prostate Disorders on February 5, 2009
Reviewed September 2011


Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer


Notify Me

Would you like us to inform you when we post new Prostate Disorders Health Alerts?

Post a Comment

Comments

Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.

The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.


After radical prostatectomy what can cause PSA measures to continue? With repeated bone/PET scans being negative what is causing PSA readings? Is it possible prostate material was left in place and is producing the PSA readings? There seems to be alot of info about prostate disorders/cancer available but not much about after radical prostatectomy. Any ideas.

Posted by: conch_1 | August 15, 2009 12:39 PM

Post a Comment


Already a subscriber?

Login

Forgot your password?

New to Johns Hopkins Health Alerts?

Register to submit your comments.

(example: yourname@domain.com)

(800) 829-0422

Registered Users Log-in:

Forgot Password?

Become a Registered User!
It's fast and FREE!
The Benefits of Being a Registered User

Health Topic Pages

  • Health Alert
  • Special Report

What is this?

XML


Johns Hopkins' Bestsellers Prostate Disorders

Our Featured Titles:

Johns Hopkins Prostate Disorders White Paper

The Johns Hopkins Prostate Bulletin Cover

  • The Johns Hopkins Prostate Disorders Bulletin
    The Johns Hopkins Prostate Disorders Bulletin is a quarterly publication that presents the latest treatment information available on prostate cancer, enlarged prostate (BPH), and prostatitis to help you take charge of your medical care for prostate disease. Each issue is like having an in-depth consultation with a leading specialist. PLUS, subscribe now and get a special discount PLUS 5 FREE Special Reports as INSTANT PDF DOWNLOADS:
    • Special Report #1: BPH (Benign Prostatic Hyperplasia)
    • Special Report #2: Diet and Prostate Health
    • Special Report #3: Treating Overactive Bladder
    • Special Report #4: Chronic Prostatitis: New Research, Renewed Hope
    • Special Report #5: The Radical Prostatectomy

    Click here to read more or order The Johns Hopkins Prostate Disorders Bulletin.


    Related Titles:

    THE JOHNS HOPKINS PROSTATE LIBRARY


    A series of cutting-edge publications designed to address your specific prostate questions.

    • Choosing the Right Treatment for Prostae Cancer
      A must-read primer for any man recently diagnosed with prostate cancer who is looking for answers to pressing questions about treatment options. Our specialists explain in-depth: proactive surveillance, also known as expectant management ... nerve-sparing radical prostatectomy . . . radiation therapy, including EBRT, 3DCRT, IMRT, IGT, and brachytherapy. Written by Jacek L. Mostwin M.D. and colleagues at the world-renowned James Buchanan Brady Urological Institute at Johns Hopkins - the hospital and urology center ranked #1 year after year by U.S. News & World Report -- Choosing the Right Treatment for Prostate Cancer takes you step-by-step through the decision-making process to help you make informed choices.
      Read More

    Restoring Sexual Intimacy After Prostate Cancer Treatment

    The Best Treatment Strategies for BPH

    • The Best Treatment Strategies for BPH
      Written by a team of top specialists at Johns Hopkins' renowned Brady Urological Institute, this essential guide presents the latest thinking on managing benign prostatic hyperplasia (BPH) or enlarged prostate. The report answers dozens of questions from patients searching for practical, no-nonsense advice on living with BPH. It provides a thorough discussion of your surgical options when medication no longer works, weighing the pros and cons of TUNA, TUMT, and TURP. Armed with the information in this guide, you'll be able to meet with your own physician and make the right decisions in your quest for the best possible outcome.
      Read more...

    The Latest Treatments for Advanced Prostate Cancer

    • The Latest Treatments for Advanced Prostate Cancer
      If you've just received the bad news that your prostate cancer has returned, America's #1 Urology Center's specialists offer this up-to-the-minute treatment guide is designed as a detailed primer on advanced prostate cancer, so you can know all your options for dealing with this major health
      Read more...